← Back to Analyst Consensus 
TENX Buy
TENAX THERAPEUTICS, INC.
Current Price —
Implied Upside —
Analysts 16
30-Day Momentum
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Next Earnings
Nov 10, 2026 (15 days)
Rating Timeline
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 31, 2026 | Guggenheim | downgrade | Buy → Neutral | — | 52% |
| Aug 11, 2026 | Chardan Capital | downgrade | Buy → Neutral | — | 47% |
| Aug 11, 2026 | Canaccord Genuity | maintain | Buy → Buy | — | 48% |
| Aug 11, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Aug 11, 2026 | Evercore ISI Group | downgrade | Outperform → In-Line | — | 58% |
| Aug 10, 2026 | William Blair | downgrade | Outperform → Market Perform | — | 48% |
| Jul 31, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Jul 29, 2026 | Cantor Fitzgerald | reiterate | Overweight → Overweight | — | 50% |
| Jul 28, 2026 | Canaccord Genuity | initiate | — → Buy | — | 48% |
| Jul 22, 2026 | Evercore ISI Group | initiate | — → Outperform | — | 58% |
| Jul 2, 2026 | Chardan Capital | maintain | Buy → Buy | — | 47% |
| Jun 24, 2026 | Cantor Fitzgerald | reiterate | Overweight → Overweight | — | 50% |
| Jun 22, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Jun 22, 2026 | Chardan Capital | initiate | — → Buy | — | 47% |
| Jun 12, 2026 | Piper Sandler | maintain | Overweight → Overweight | — | 54% |
| Mar 17, 2026 | Cantor Fitzgerald | initiate | — → Overweight | — | 50% |
| Mar 16, 2026 | Guggenheim | maintain | Buy → Buy | — | 52% |
| Dec 17, 2025 | Guggenheim | maintain | Buy → Buy | $25 | 52% |
| Sep 8, 2025 | Piper Sandler | initiate | — → Overweight | $20 | 54% |
| Aug 14, 2025 | Guggenheim | maintain | Buy → Buy | $14 | 52% |
| Oct 24, 2024 | Leerink Partners | initiate | — → Outperform | $16 | 51% |
| Feb 20, 2024 | Roth MKM | reiterate | Buy → Buy | $30 | 52% |
Price Target Trend
Apr 22, 2026 Latest: $9.63 Oct 24, 2026
EPS Estimates
0q $-0.36
Lo: $-0.39 Hi: $-0.33
7 analysts ▲2
+1q $-0.38
Lo: $-0.43 Hi: $-0.34
7 analysts ▲1
0y $-1.45
Lo: $-1.75 Hi: $-1.15
9 analysts ▲3
+1y $-1.50
Lo: $-1.74 Hi: $-1.29
7 analysts ▲2
Cross-Platform Signals
No cross-platform signals in the last 90 days